North America Human Leukocyte Antigen Testing Market Report 2022: Rising Government Funding for Organ Donation Presents Opportunities – ResearchAndMarkets.com

0

DUBLIN–(BUSINESS WIRE)–The Report “North America Human Leukocyte Antigen Testing Market Forecast to 2028 – Impact of COVID-19 and Regional Analysis by Product & Service, Technology, and End User” has been added to from ResearchAndMarkets.com offer.

North America Human Leukocyte Antigen (HLA) Testing Market is expected to grow from US$324.49 million in 2022 to US$504.72 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Human leukocyte antigens (HLA) are specialized proteins found on all cell surfaces of the human body except red blood cells. The HLA test has significant application in organ transplantation, which may be recommended as part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical conditions.

The increasing prevalence of chronic diseases and organ failures leads to a high demand for organ transplant procedures, as well as HLA testing. Before the transplant, an HLA test is carried out to check the tissue compatibility between the patients and the donors in order to avoid the rejection of the graft. In recent years, transplantation has become a thriving area of ​​practice. Governments in various countries are taking initiatives to raise public awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures.

For example, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplant procedures in the United States. These strategies aim to increase the number of organ and tissue transplants in patients with end-stage organic disease, change the current distribution of organs, and change the organ transplant waiting list by redistributing existing organs.

In addition, the OPTN has used novel strategies to improve organ transplantation. These innovative strategies include the optimized use of organs removed from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], the reduction of organ rejection, the promotion of living donation and the improvement of the potential authorization rate for organ donation. Thus, the growing demand for organ transplantation is leading to the requirement for more HLA test kits and consumables, which is driving the HLA testing market.

With new features and technologies, vendors can attract new customers and expand their footprint in emerging markets. This factor is likely to drive the North American Human Leukocyte Antigen (HLA) Testing market at a notable CAGR during the forecast period.

Market dynamics

Market factors

  • Increased number of plasma donation and organ transplant procedures

  • Extension of the range of applications of the HLA test

Market constraints

Market opportunities

  • Increase in government funding for organ donation

Future trends

  • Technological advances in the field of histocompatibility

North America Human Leukocyte Antigen (HLA) Testing Market Segmentation

The North America human leukocyte antigen (HLA) testing market is segmented into products and services, technology, end-user, and country.

  • On the basis of products and services, the market is segmented into reagents and consumables, instruments and software, and services. In terms of technology, the North American human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular analysis technologies segment is sub-segmented into PCR-based molecular analyses, sequencing-based molecular analyzes and others.

  • Based on the end user, the market is divided into independent reference laboratories, hospital centers and transplant centers, etc.

  • Based on countries, the North American human leukocyte antigen (HLA) testing market is segmented into the United States, Mexico, and Canada.

Main topics covered:

1. Introduction

2. North America Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways

3. Research methodology

4. North America Human Leukocyte Antigen (HLA) Testing Market – Market Landscape

5. North America Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

6. North America Human Leukocyte Antigen (HLA) Testing Market – Analysis

7. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – By Product and Services

8. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – By Technology

9. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – By End User

10. North America Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – By Country

11. North America Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape

12. Company Profiles

13. Appendix

Companies cited

  • ThermoFisher Scientific.

  • CareDx

  • QIAGEN

  • Illumina, Inc.

  • Bio-Rad Laboratories, Inc.

  • TBG Diagnostics Limited

  • F. Hoffman LaRoche

  • Takara Bio Inc.

  • Luminex Corporation

  • Omixon inc.

  • The sequencing center

  • HistoGenetics LLC

  • CD Genomics

  • Quintara Biosciences

  • Creative biolabs

For more information about this report visit https://www.researchandmarkets.com/r/fa72g2

Share.

Comments are closed.